NCT06418620View on ClinicalTrials.gov

A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

August 7, 2020

Study Completion Date

August 7, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Venglustat

Pharmaceutical form:Tablet-Route of administration:Oral

Trial Locations (1)

55114

Prism Research Site Number : 8400001, Saint Paul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY